G Medical Innovations Holdings (G Medical Innovations Holdings) Total Inventories : $0.29 Mil (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings Total Inventories?

G Medical Innovations Holdings's total inventories for the quarter that ended in Dec. 2022 was $0.29 Mil. G Medical Innovations Holdings's average total inventories from the quarter that ended in Jun. 2022 to the quarter that ended in Dec. 2022 was $1.32 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. G Medical Innovations Holdings's Net-Net Working Capital per share for the quarter that ended in Dec. 2022 was $-7.37.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. G Medical Innovations Holdings's Inventory Turnover for the quarter that ended in Dec. 2022 was -2.67.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. G Medical Innovations Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2022 was 0.60.

G Medical Innovations Holdings Total Inventories Historical Data

The historical data trend for G Medical Innovations Holdings's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings Total Inventories Chart

G Medical Innovations Holdings Annual Data

Trend

Sep16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Inventories

Get a 7-Day Free Trial

1.36

0.38

0.09

0.36

0.29

G Medical Innovations Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Total Inventories	Get a 7-Day Free Trial							0.09	0.05	0.36	2.34	0.29

G Medical Innovations Holdings Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

G Medical Innovations Holdings (OTCPK:GMVDF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

G Medical Innovations Holdings's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2022 is

	Net-Net Working Capital Per Share (Q: Dec. 2022 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.295	+	0.75 * 0.593	+	0.5 * 0.292	-	9.396
-	0	-	2.782)	/	1.53279
=	-7.37

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

G Medical Innovations Holdings's Days Inventory for the six months ended in Dec. 2022 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2022 )	/	Cost of Goods Sold (Q: Dec. 2022 )	*	Days in Period
	=	1.315	/	-3.505	*	365 / 2
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

G Medical Innovations Holdings's Inventory Turnover for the quarter that ended in Dec. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2022 )	/	Average Total Inventories (Q: Dec. 2022 )
	=	-3.505	/	1.315
	=	-2.67

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

G Medical Innovations Holdings's Inventory to Revenue for the quarter that ended in Dec. 2022 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2022 )	/	Revenue (Q: Dec. 2022 )
	=	1.315	/	2.196
	=	0.60

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

G Medical Innovations Holdings Total Inventories Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Oppenheimer Street, Rehovot, ISR, 7670105

Website

https://www.gmedinnovations.com

G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.

Executives

Awm Investment Company, Inc.

10 percent owner

527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022